Metastatic pituitary lesion

• Published in: Problemy ėndokrinologii 2024-11, Vol.70 (5), p.46-53
• Main Authors: Lapshina, A. M., Bazarova, E. A., Przhialkovskaya, E. G., Khandaeva, P. M., Azizyan, V. N., Grigoriev, A. Yu, Ivashchenko, O. V., Tarbaeva, N. V., Belaya, Zh. E.
• Format: Article
• Language: eng ; rus
• ISSN: 0375-9660; 2308-1430
• DOI: 10.14341/probl13395

Metastatic lesion of pituitary is a rare condition and is diagnosed in 1.8–4% of cases. Monitoring and treatment of such patients is a complex task and requires increased attention from a multidisciplinary team of specialists. The authors represent three patients with metastatic pituitary lesion who underwent neurosurgical treatment at the National Research Center of the National Research Institute of Endocrinology with subsequent pathomorphological confirmation of the diagnosis. The primary tumors were breast cancer, lung carcinoid, and clear cell kidney cancer. Two patients had distant metastases other than the pituitary gland. The clinical manifestation consisted in the appearance of symptoms of panhypopituitarism, chiasmal syndrome and mass effect in all cases. The follow-up period after surgical treatment was 0.25–2.5 years. Progression of the underlying disease was noted in two patients. One of them carried out stereotactic radiosurgical treatment and stereotactic oriented irradiation. One patient has a stable condition.